Kirby McInerney LLP is investigating potential claims against the Board of Directors of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (NASDAQ:ANGO) for possible breaches of fiduciary duty and other violations of state law.

The investigation focuses on allegations that certain statements issued by the Company, between October 9, 2014 and April 9, 2015, regarding AngioDynamics’ business, operations, and prospects were false or misleading. On April 9, 2015 the Company announced its financial results for the third quarter fiscal 2015. The Company reported a quarterly loss of $4.3 million and advised investors of a downgrade in its full year outlook by nearly 4%. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you are an AngioDynamics stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, or telephone at (212) 699-1145, or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.